Kiatichai Faksri

Biographic Data

ID9067237
NAMEKiatichai Faksri
GIVEN NAMESKiatichai
FAMILY NAMEFaksri
SIGNATUREFAKSRI K
VERIFIEDNo
TOTAL WORKS8
TOTAL CITATIONS0
WORKS AS AUTHOR0
WORKS AS EDITOR8
FIRST PUBLICATION YEAR2023
LATEST PUBLICATION YEAR2026
H-INDEX0

  • A novel framework for quantifying the clinical impact of substandard and falsified antimicrobials

    Open AccessSean Cavany, Lawrence Adipo et al.EDITORARTICLEPLOS Global Public Health2026

    Substandard and falsified (SF) medicines are a neglected public health threat, with an estimated 7% of antimicrobials in low- and middle-income countries being SF. However, quantifying their clinical impact remains challenging. We developed a general framework for estimating population-level impacts of SF antimicrobials on patient outcomes and apply it to SF fluoroquinolones in typhoid treatment. The framework combines two data sources: published…

  • Burden, clinical impact, and primary antimicrobial resistance profiles of Helicobacter pylori infections in Cameroon

    Open AccessEliane V Assokom Okoubalimba, Judith G L F Ekwe Priso et al.EDITORARTICLEPLOS Global Public Health2026

    Helicobacter pylori is one of the most widespread pathogens in humans and a strong predictor of gastric cancers. This systematic review and meta-analysis (PROSPERO: CRD420261375391) aimed at determining the extent, clinical impact, and antibiotic resistance profile of H. pylori infections in Cameroon. Six databases were exploited to identify relevant studies published between 2000 and 2026, as per PRISMA guidelines. Pooled proportions were comput…

  • Cost-effectiveness of BPaL-based and 9-month modified all-oral short treatment regimens for rifampicin-resistant tuberculosis in Belarus

    Open AccessNatalia Yatskevich, Kiatichai FaksriEDITORARTICLEPLOS Global Public Health2026

    Belarus remains a high-burden country for multidrug-/rifampicin-resistant tuberculosis (MDR/RR-TB), including pre-extensively drug-resistant TB (pre-XDR-TB). BPaL-based and modified 9-month short treatment regimens (mSTR), implemented under operational research conditions, have demonstrated improved clinical outcomes, but evidence on their cost-effectiveness in real-world settings remains limited. We evaluated the cost-effectiveness of BPaL-based…

  • Prevalence of rifampicin resistance in pulmonary tuberculosis

    Open AccessIsrael Bedzina, Agnes Naa Larley Lartey et al.EDITORARTICLEPLOS Global Public Health2025

    Tuberculosis (TB) remains a significant global public health challenge, particularly in low- and middle-income countries. The emergence of rifampicin-resistant tuberculosis further complicates control efforts. Despite national efforts, there are limited data on the prevalence of Mycobacterium tuberculosis and their rifampicin resistance in Ghana, especially at the facility level. This study aimed to determine the prevalence of Mycobacterium tuber…

  • Diagnostic yield of nine user-friendly bioinformatics tools for predicting Mycobacterium tuberculosis drug resistance

    Open AccessYa-Li Chen, Yu He et al.EDITORARTICLEPLOS Global Public Health2025

    To compare the diagnostic yield of various bioinformatics tools for predicting Mycobacterium tuberculosis drug resistance. A systematic review of PubMed, Embase, Scopus, Web of Science, CINAHL and the Cochrane Library was performed to identify studies reporting the effectiveness of bioinformatic tools for predicting resistance to anti-tuberculosis (TB) drugs. Data were collected and pooled using random-effects meta-analysis and Bayesian network m…

  • Metabolite dynamics over the course of anti-tuberculosis treatment in individuals with mild and severe tuberculosis

    Open AccessCatherine H Kagemann, Senbagavalli Prakash Babu et al.EDITORARTICLEPLOS Global Public Health2025

    Mycobacterium tuberculosis (Mtb) manipulates host metabolism to gain nutrients and increase virulence. Despite known alterations in metabolism in individuals with pulmonary tuberculosis (PTB) during anti-tuberculosis (TB) treatment, the effect of disease severity on metabolite dynamics in individuals with PTB remains understudied. We examined metabolite dynamics over the course of anti-TB treatment in individuals diagnosed with mild (N = 8; smear…

  • Exposure to bovine livestock and latent tuberculosis infection in children

    Open AccessMartine Augusta Flore Tsasse, Henry Dilonga Meriki et al.EDITORARTICLEPLOS Global Public Health2024

    Bovine tuberculosis (bTB), a neglected zoonotic disease, is endemic in cattle in many Sub-saharan African countries, yet its contribution to tuberculosis (TB) burden is understudied. Rapid urbanisation and increase in demand for animal proteins, including dairy products, increases the risk of spill over. This study compared the latent tuberculosis infection (LTBI) risk in children, a proxy-measure for recent TB infection, in children living in hi…

  • Prevalence and risk factors of M tuberculosis infection in young people across 14 communities in Zambia and South Africa

    Open AccessModupe Amofa-Sekyi, Ab Schaap et al.EDITORARTICLEPLOS Global Public Health2023

    Background From 2018–2021 the TB Reduction through Expanded Antiretroviral Treatment and TB Screening (TREATS) project took place in 21 Zambian and South African communities. The TREATS Incidence of TB Infection Cohort Study was conducted in adolescents and young people (AYP), aged 15–24 years in 14 communities. We describe the baseline prevalence and risk factors of Mycobacterium tuberculosis ( M . tuberculosis) infection among this cohort and e…